195 related articles for article (PubMed ID: 38632022)
21. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.
Olszewski AJ; Fallah J; Castillo JJ
Cancer; 2016 Sep; 122(17):2689-97. PubMed ID: 27337679
[TBL] [Abstract][Full Text] [Related]
22. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
23. Tumor lysis syndrome as a risk factor for very early mortality in HIV-associated non-Hodgkin's lymphoma: A 10-year single-center experience.
Chang YY; Chang CH; Ku WW; Gau JP; Yu YB
J Chin Med Assoc; 2020 Apr; 83(4):371-376. PubMed ID: 32101892
[TBL] [Abstract][Full Text] [Related]
24. [Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].
Pizarro A; García H; Riquelme A; Carmona J; Cortés C
Rev Chilena Infectol; 2013 Feb; 30(1):23-30. PubMed ID: 23450406
[TBL] [Abstract][Full Text] [Related]
25. Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy.
Gondwe Y; Kudowa E; Tomoka T; Kasonkanji ED; Kaimila B; Zuze T; Mumba N; Kimani S; Mulenga M; Chimzimu F; Kampani C; Randall C; Lilly A; Gopal S; Fedoriw Y; Painschab M
PLoS One; 2022; 17(9):e0273408. PubMed ID: 36048901
[TBL] [Abstract][Full Text] [Related]
26. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
Montoto S; Shaw K; Okosun J; Gandhi S; Fields P; Wilson A; Shanyinde M; Cwynarski K; Marcus R; de Vos J; Young AM; Tenant-Flowers M; Orkin C; Johnson M; Chilton D; Gribben JG; Bower M
J Clin Oncol; 2012 Nov; 30(33):4111-6. PubMed ID: 23045581
[TBL] [Abstract][Full Text] [Related]
27. Changing Patterns of Lymphoma in the Antiretroviral Therapy Era in Johannesburg, South Africa.
Wiggill T; Mayne E; Perner Y; Vaughan J
J Acquir Immune Defic Syndr; 2021 Nov; 88(3):252-260. PubMed ID: 34354010
[TBL] [Abstract][Full Text] [Related]
28. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with survival in patients with lymphoma and HIV.
Vargas JC; Marques MO; Pereira J; Braga WMT; Hamerschlak N; Tabacof J; Ferreira PRA; Colleoni GWB; Baiocchi OCG
AIDS; 2023 Jul; 37(8):1217-1226. PubMed ID: 36939075
[TBL] [Abstract][Full Text] [Related]
30. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
31. [HIV-associated malignant lymphomas].
Egli F; Baumann R; Bernasconi E; Opravil M
Schweiz Med Wochenschr; 1992 Apr; 122(14):495-502. PubMed ID: 1348590
[TBL] [Abstract][Full Text] [Related]
32. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States.
Howlader N; Shiels MS; Mariotto AB; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin Lymphoma in People Living with HIV.
Navarro JT; Moltó J; Tapia G; Ribera JM
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503176
[TBL] [Abstract][Full Text] [Related]
34. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance.
Lim KJC; Di Ciaccio P; Polizzotto MN; Milliken S; Cochrane T; Goh Z; Shaw B; Perry E; Gilbertson M; Kermode W; Cheah CY; Latimer M; Hamad N; Ku M
Br J Haematol; 2023 Jun; 201(5):865-873. PubMed ID: 36866733
[TBL] [Abstract][Full Text] [Related]
36. [Non-Hodgkin lymphomas with systemic presentation in patients with HIV infection. Clinical and prognostic factors in a series evaluated before the introduction of the highly active antiretroviral therapy (HAART)].
Segura Huerta A; López Tendero P; Romera Barroso B; Yuste Izquierdo AL; Gironés Sarrió R; Pérez Fidalgo JA; Gómez Codina J; López Aldeguer J
Rev Clin Esp; 2004 Jun; 204(6):303-7. PubMed ID: 15171891
[TBL] [Abstract][Full Text] [Related]
37. Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent Prognosis.
Kriegsmann K; Klee JS; Hensel M; Buss EC; Kriegsmann M; Cremer M; Ho AD; Egerer G; Wuchter P; Witzens-Harig M
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):e581-e587. PubMed ID: 31377211
[TBL] [Abstract][Full Text] [Related]
38. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors.
Miralles P; Berenguer J; Ribera JM; Rubio R; Mahillo B; Téllez MJ; Lacruz J; Valencia E; Santos J; Rodríguez-Arrondo F; Pintado V;
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):167-73. PubMed ID: 17117144
[TBL] [Abstract][Full Text] [Related]
40. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]